Literature DB >> 1535685

Novel revertants of H-ras oncogene-transformed R6-PKC3 cells.

R S Krauss1, S N Guadagno, I B Weinstein.   

Abstract

Rat 6 fibroblasts that overproduce protein kinase C beta 1 (R6-PKC3 cells) are hypersensitive to complete transformation by the T24 H-ras oncogene; yet T24 H-ras-transformed R6-PKC3 cells are killed when exposed to 12-O-tetradecanoylphorbol-13-acetate (TPA) (W.-L. W. Hsiao, G. M. Housey, M. D. Johnson, and I. B. Weinstein, Mol. Cell. Biol. 9:2641-2647, 1989). Treatment of an R6-PKC3 subclone that harbors a T24 H-ras gene under the control of an inducible mouse metallothionein I promoter with ZnSO4 and TPA is extremely cytocidal. This procedure was used to isolate rare revertants that are resistant to this toxicity. Two revertant lines, R-1a and ER-1-2, continue to express very high levels of protein kinase C enzyme activity but, unlike the parental cells, do not grow in soft agar. Furthermore, these revertants are resistant to the induction of anchorage-independent growth by the v-src, v-H-ras, v-raf, and, in the case of the R-1a line, v-fos oncogenes. Both revertant lines, however, retain the ability to undergo morphological alterations when either treated with TPA or infected with a v-H-ras virus, thus dissociating anchorage independence from morphological transformation. The revertant phenotype of both R-1a and ER-1-2 cells is dominant over the transformed phenotype in somatic cell hybridizations. Interestingly, the revertant lines no longer induce the metallothionein I-T24 H-ras construct or the endogenous metallothionein I and II genes in response to three distinct agents: ZnSO4, TPA, and dexamethasone. The reduction in activity of metallothionein promoters seen in these revertants may reflect defects in signal transduction pathways that control the expression of genes mediating specific effects of protein kinase C and certain oncogenes in cell transformation.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1535685      PMCID: PMC364526          DOI: 10.1128/mcb.12.7.3117-3129.1992

Source DB:  PubMed          Journal:  Mol Cell Biol        ISSN: 0270-7306            Impact factor:   4.272


  72 in total

1.  A novel, plasmid-based system for studying gene rearrangements in mammalian cells.

Authors:  R S Krauss; I B Weinstein
Journal:  Mol Cell Biol       Date:  1991-08       Impact factor: 4.272

2.  A dominant suppressive mutation in a cellular gene restores the nontransformed phenotype to v-fms-transformed mink cells.

Authors:  J Kato; C J Sherr
Journal:  Oncogene       Date:  1991-05       Impact factor: 9.867

Review 3.  Complexities of the protein kinase C pathway.

Authors:  P M Blumberg
Journal:  Mol Carcinog       Date:  1991       Impact factor: 4.784

4.  v-Src activates both protein kinase C-dependent and independent signaling pathways in murine fibroblasts.

Authors:  S A Qureshi; C K Joseph; M Rim; A Maroney; D A Foster
Journal:  Oncogene       Date:  1991-06       Impact factor: 9.867

5.  Cells that overproduce protein kinase C are more susceptible to transformation by an activated H-ras oncogene.

Authors:  W L Hsiao; G M Housey; M D Johnson; I B Weinstein
Journal:  Mol Cell Biol       Date:  1989-06       Impact factor: 4.272

6.  Activation of junB by PKC and PKA signal transduction through a novel cis-acting element.

Authors:  R P de Groot; J Auwerx; M Karperien; B Staels; W Kruijer
Journal:  Nucleic Acids Res       Date:  1991-02-25       Impact factor: 16.971

7.  Failure of wild-type or a mutant form of protein kinase C-alpha to transform fibroblasts.

Authors:  C Borner; I Filipuzzi; I B Weinstein; R Imber
Journal:  Nature       Date:  1991-09-05       Impact factor: 49.962

8.  Overexpression of the alpha-type protein kinase (PK) C in LLC-PK1 cells does not lead to a proportional increase in the induction of two 12-O-tetradecanoylphorbol-13-acetate-inducible genes.

Authors:  M Wartmann; D A Jans; P J Parker; Y Nagamine; B A Hemmings; S Jaken; U Eppenberger; D Fabbro
Journal:  Cell Regul       Date:  1991-06

9.  Isolation and characterization of PKC-L, a new member of the protein kinase C-related gene family specifically expressed in lung, skin, and heart.

Authors:  N Bacher; Y Zisman; E Berent; E Livneh
Journal:  Mol Cell Biol       Date:  1991-01       Impact factor: 4.272

10.  Induction of proto-oncogene JUN/AP-1 by serum and TPA.

Authors:  W W Lamph; P Wamsley; P Sassone-Corsi; I M Verma
Journal:  Nature       Date:  1988-08-18       Impact factor: 49.962

View more
  7 in total

1.  Identification of a role for the sialomucin CD164 in myogenic differentiation by signal sequence trapping in yeast.

Authors:  Y N Lee; J S Kang; R S Krauss
Journal:  Mol Cell Biol       Date:  2001-11       Impact factor: 4.272

2.  Ras induces anchorage-independent growth by subverting multiple adhesion-regulated cell cycle events.

Authors:  J S Kang; R S Krauss
Journal:  Mol Cell Biol       Date:  1996-07       Impact factor: 4.272

3.  Ras signals to the cell cycle machinery via multiple pathways to induce anchorage-independent growth.

Authors:  J J Yang; J S Kang; R S Krauss
Journal:  Mol Cell Biol       Date:  1998-05       Impact factor: 4.272

4.  Cellular aging is a critical determinant of primary cell resistance to v-src transformation.

Authors:  N Tavoloni; H Inoue
Journal:  J Virol       Date:  1997-01       Impact factor: 5.103

5.  CDO, a robo-related cell surface protein that mediates myogenic differentiation.

Authors:  J S Kang; P J Mulieri; C Miller; D A Sassoon; R S Krauss
Journal:  J Cell Biol       Date:  1998-10-19       Impact factor: 10.539

6.  Role of the F-box protein Skp2 in adhesion-dependent cell cycle progression.

Authors:  A C Carrano; M Pagano
Journal:  J Cell Biol       Date:  2001-06-25       Impact factor: 10.539

7.  CDO: an oncogene-, serum-, and anchorage-regulated member of the Ig/fibronectin type III repeat family.

Authors:  J S Kang; M Gao; J L Feinleib; P D Cotter; S N Guadagno; R S Krauss
Journal:  J Cell Biol       Date:  1997-07-14       Impact factor: 10.539

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.